Cargando…
P053 Invasive Mucormycosis (Zygomycosis) -Pre-Covid Era and Covid Era: a retrospective study at a tertiary care centre, chennai
POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: To compare the prevalence and clinical presentation of Mucormycosis in pre-COVID era (January 2017-December 2019) and COVID era (January 2020-till date). To compare the AFST pattern of the zygomycetes causing Mucormycosis in pre...
Autores principales: | K, Malavika, Thayanidhi, Premamalini, P, Sathyamurthy, Kindo, Anupma Jyoti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509899/ http://dx.doi.org/10.1093/mmy/myac072.P053 |
Ejemplares similares
-
Rise of mucormycosis during the COVID-19 pandemic and the challenges faced
por: Kottarathil, Malavika, et al.
Publicado: (2023) -
P022 Luliconazole—a novel potent imidazole activity against Aspergillus niger and Aspergillus flavus causing otomycosis
por: Sukumar, Bavadharani, et al.
Publicado: (2022) -
In Vitro
Production of Virulence Factors and Antifungal Susceptibility Pattern of
Aspergillus
Isolates from Clinical Samples in a Tertiary Care Center
por: Bavadharani, Sukumar, et al.
Publicado: (2022) -
Evaluation of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide method for assessing biofilm formation in vitro by Trichosporon spp.
por: Premamalini, Thayanidhi, et al.
Publicado: (2018) -
P426 Interleukins—a non-invasive biomarker for invasive fungal sinusitis
por: Kadhirvelu, Hemanth Kumar, et al.
Publicado: (2022)